サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1394153

成長因子の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、グレード別、用途別、エンドユーザー別、地域別

Growth Factors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

出版日
ページ情報
英文 391 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
成長因子の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、グレード別、用途別、エンドユーザー別、地域別
出版日: 2023年12月06日
発行: Fairfield Market Research
ページ情報: 英文 391 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の成長因子の市場規模は、2024年の22億米ドルから2031年末には38億米ドルになると予測され、大幅な拡大が見込まれています。この成長を推進する上で極めて重要な役割を果たしているのが製造業者であり、皮膚再生、創傷治癒、治療用途に革命をもたらしています。

成長因子は皮膚再生と創傷治癒の礎石として登場しました。研究者たちは、単一の成長因子ソリューションにとどまらない先駆的な製品の開発に熱心に取り組んでおり、市場に大きな成長機会への道を開いています。さらに、アジア太平洋地域の急成長と、適正製造基準（GMP）グレードの製品を専門とする限られた数の企業が、成長因子メーカーに大きな可能性をもたらしています。

さまざまな疾患の治療におけるサイトカインおよび成長因子の治療可能性は、市場の拡大を後押しすると予想されます。自己免疫疾患とがんの有病率の上昇は、この成長軌道をさらに促進します。

業界をリードする参入企業は、新製品の承認、上市、共同研究、契約、提携に戦略的に注力しています。これらの戦略は、製品ポートフォリオを強化し、地域的プレゼンスを拡大することを目的としています。研究開発への投資とともにM&Aも、さまざまな治療・科学領域で成長要因を活用するための主な戦略です。

しかし、成長因子市場は、主に高コストと熟練した専門家の不足に起因する課題に直面しています。特定の成長因子のコストが、研究室での採用を妨げています。有資格の専門家が少なく、必要な機器や付属品へのアクセスが限られていることが、市場の拡大をさらに妨げています。

当レポートでは、世界の成長因子市場について調査し、市場の概要とともに、製品別、グレード別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界の成長因子市場の見通し、2018年～2031年

  • 世界の成長因子市場の見通し、製品別、金額、数量、2018年～2031年
  • 世界の成長因子市場の見通し、グレード別、金額、数量、2018年～2031年
  • 世界の成長因子市場の見通し、用途別、金額、数量、2018年～2031年
  • 世界の成長因子市場の見通し、エンドユーザー別、金額、数量、2018年～2031年
  • 世界の成長因子市場の見通し、地域別、金額、数量、2018年～2031年

第4章 北米の成長因子市場の見通し、2018年～2031年

第5章 欧州の成長因子市場の見通し、2018年～2031年

第6章 アジア太平洋の成長因子市場の見通し、2018年～2031年

第7章 ラテンアメリカの成長因子市場の見通し、2018年～2031年

第8章 中東・アフリカの成長因子市場の見通し、2018年～2031年

第9章 競合情勢

  • 用途別とグレード別のヒートマップ
  • メーカーとグレード別のヒートマップ
  • 企業の市場シェア分析、2023年
  • 競争力ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Lonza Group AG
    • Merck KGaA
    • General Electronics Company
    • F. Hoffmann-La Roche Ltd
    • Applied Biological Materials (abm), Inc
    • Abcam plc.
    • Cell Signaling Technology, Inc.
    • Sartorius CellGenix GmbH
    • Bio-Techne
    • Proteintech Group, Inc
    • Miltenyi Biotec
    • Creative Bioarray
    • Akron Biotech
    • Sino Biological Inc.
    • Repligen corporation
    • LEADGENE BIOMEDICAL, INC.
    • PeproTech In

第10章 付録

目次

The global growth factors market is poised for substantial expansion, with a remarkable surge in revenue from US $2.2 billion in 2024 to an estimated US $3.8 billion by the end of 2031. Manufacturers are playing a pivotal role in propelling this growth, revolutionizing skin regeneration, wound healing, and therapeutic applications.

Manufacturers Spearhead Market Growth

Growth factors have emerged as a cornerstone for skin regeneration and wound healing. Researchers are diligently working on pioneering products that extend beyond single growth factor solutions, paving the way for significant opportunities in the market. Additionally, the rapid growth of the Asia Pacific region and a limited number of companies specializing in Good Manufacturing Practice (GMP)-grade products create vast prospects for growth factor manufacturers.

Cytokine and Growth Factors Therapy Expands

The therapeutic potential of cytokine and growth factors in treating a range of disorders is expected to bolster market expansion. The rising prevalence of autoimmune diseases and cancer further fuels this growth trajectory.

Key Players Drive Expansion

Leading industry players are strategically focusing on new product approvals, launches, collaborations, agreements, and partnerships. These tactics are aimed at strengthening product portfolios and expanding regional presence. Mergers and acquisitions, along with investments in research and development, are also key strategies to harness growth factors in various therapeutic and scientific domains.

Challenges Ahead

However, the growth factors market faces its share of challenges, primarily stemming from high costs and a shortage of skilled professionals. The cost of certain growth factors hampers their adoption in research laboratories. A dearth of qualified experts and limited access to necessary equipment and accessories further impede market expansion.

Country-wise Insights

Why the U.S. is Thriving

The United States is witnessing a burgeoning demand for growth factors, driven by government initiatives supporting research activities and the growing importance of growth factors and cytokines in stem cell biology.

China's Emergence

China has become a prominent market for growth factors, particularly in the wake of the COVID-19 pandemic. As larger Chinese companies focus on developing growth factor-based medicines to combat the virus, the market for these products is rapidly expanding throughout China and East Asia.

Germany's Appeal

Germany stands out as a lucrative market for growth factors in Europe due to rising healthcare spending and the presence of robust manufacturing facilities. Major companies are expanding their product offerings through strategic acquisitions, such as Sartorius AG's acquisition of CellGenix in 2021 to bolster its cell and gene therapy product line.

Competitive Landscape

Key players in the growth factors market, including Thermo Fisher Scientific, Lonza Group AG, Merck KGaA, and others, are actively pursuing strategies to enhance their global presence. These strategies encompass new product releases, business expansion, approvals, partnerships, agreements, collaborations, and diversified distribution channels, including online sales.

Key Companies Profiled:

  • Thermo Fisher Scientific
  • Lonza Group AG
  • Merck KGaA
  • General Electronics Company
  • F. Hoffmann-La Roche Ltd
  • Applied Biological Materials (abm), Inc
  • Abcam plc.
  • Cell Signaling Technology, Inc.
  • Meridian Bioscience Inc.
  • Sartorius CellGenix GmbH
  • Bio-Techne.
  • Proteintech Group, Inc.
  • Miltenyi Biotec
  • Creative Bioarray
  • Akron Biotech
  • Sino Biological Inc.
  • Repligen Corporation
  • LEADGENE BIOMEDICAL, INC.
  • PeproTech Inc.

Key Segments of the Growth Factors Industry Research:

By Product:

  • Transforming Growth Factors (TGF)

Activin

  • Bone Morphogenetic Proteins (BMPs)

TGF-beta Proteins

  • Epidermal Growth Factors (EGFs)
  • Platelet-Derived Growth Factors (PDGFs)
  • Fibroblast Growth Factors (FGFs)
  • Insulin-like Growth Factors (IGFs)
  • Vascular Endothelial Growth Factors (VEGFs)
  • Hepatocyte Growth Factors (HGFs)
  • Tumour Necrosis Factors (TNFs)
  • Interleukins
  • Others

By Grade:

  • GMP Grade
  • NON-GMP Grade

By Application:

  • Oncology Research
  • Hematology Research
  • Wound Healing Research
  • Dermatology Research
  • Cardiovascular Disease & Diabetes
  • Cell therapy and Ex vivo manufacturing
  • Others

By End User:

  • Pharmaceutical and Biotechnology Companies
  • Research Centres & Academic Institutes
  • CMO and CDMO

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Growth Factors Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Growth Factors Market Outlook, 2018 - 2031

  • 3.1. Global Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Transforming Growth Factors (TGF)
        • 3.1.1.1.1. Activin
        • 3.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 3.1.1.1.3. TGF-beta Proteins
      • 3.1.1.2. Epidermal Growth Factors (EGFs)
      • 3.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 3.1.1.4. Fibroblast Growth Factors (FGFs)
      • 3.1.1.5. Insulin-like Growth Factors (IGFs)
      • 3.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 3.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 3.1.1.8. Tumour Necrosis Factors (TNFs)
      • 3.1.1.9. Interleukins
      • 3.1.1.10. Others
  • 3.2. Global Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. GMP Grade
      • 3.2.1.2. NON-GMP Grade
  • 3.3. Global Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Oncology Research
      • 3.3.1.2. Hematology Research
      • 3.3.1.3. Wound Healing Research
      • 3.3.1.4. Dermatology Research
      • 3.3.1.5. Cardiovascular Disease & Diabetes
      • 3.3.1.6. Cell therapy and Ex vivo manufacturing
      • 3.3.1.7. Others
  • 3.4. Global Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Pharmaceutical and Biotechnology Companies
      • 3.4.1.2. Research Centres & Academic Institutes
      • 3.4.1.3. CMO and CDMO
  • 3.5. Global Growth Factors Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Growth Factors Market Outlook, 2018 - 2031

  • 4.1. North America Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Transforming Growth Factors (TGF)
        • 4.1.1.1.1. Activin
        • 4.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 4.1.1.1.3. TGF-beta Proteins
      • 4.1.1.2. Epidermal Growth Factors (EGFs)
      • 4.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 4.1.1.4. Fibroblast Growth Factors (FGFs)
      • 4.1.1.5. Insulin-like Growth Factors (IGFs)
      • 4.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 4.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 4.1.1.8. Tumour Necrosis Factors (TNFs)
      • 4.1.1.9. Interleukins
      • 4.1.1.10. Others
  • 4.2. North America Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. GMP Grade
      • 4.2.1.2. NON-GMP Grade
  • 4.3. North America Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Oncology Research
      • 4.3.1.2. Hematology Research
      • 4.3.1.3. Wound Healing Research
      • 4.3.1.4. Dermatology Research
      • 4.3.1.5. Cardiovascular Disease & Diabetes
      • 4.3.1.6. Cell therapy and Ex vivo manufacturing
      • 4.3.1.7. Others
  • 4.4. North America Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Pharmaceutical and Biotechnology Companies
      • 4.4.1.2. Research Centres & Academic Institutes
      • 4.4.1.3. CMO and CDMO
  • 4.5. North America Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.2. U.S. Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.3. U.S. Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.4. U.S. Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.5. Canada Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.6. Canada Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.7. Canada Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.8. Canada Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Growth Factors Market Outlook, 2018 - 2031

  • 5.1. Europe Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Transforming Growth Factors (TGF)
        • 5.1.1.1.1. Activin
        • 5.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 5.1.1.1.3. TGF-beta Proteins
      • 5.1.1.2. Epidermal Growth Factors (EGFs)
      • 5.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 5.1.1.4. Fibroblast Growth Factors (FGFs)
      • 5.1.1.5. Insulin-like Growth Factors (IGFs)
      • 5.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 5.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 5.1.1.8. Tumour Necrosis Factors (TNFs)
      • 5.1.1.9. Interleukins
      • 5.1.1.10. Others
  • 5.2. Europe Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. GMP Grade
      • 5.2.1.2. NON-GMP Grade
  • 5.3. Europe Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Oncology Research
      • 5.3.1.2. Hematology Research
      • 5.3.1.3. Wound Healing Research
      • 5.3.1.4. Dermatology Research
      • 5.3.1.5. Cardiovascular Disease & Diabetes
      • 5.3.1.6. Cell therapy and Ex vivo manufacturing
      • 5.3.1.7. Others
  • 5.4. Europe Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Pharmaceutical and Biotechnology Companies
      • 5.4.1.2. Research Centres & Academic Institutes
      • 5.4.1.3. CMO and CDMO
  • 5.5. Europe Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.2. Germany Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.3. Germany Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.4. Germany Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.5. U.K. Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.6. U.K. Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.7. U.K. Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.8. U.K. Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.9. France Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.10. France Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.11. France Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.12. France Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.13. Italy Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.14. Italy Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.15. Italy Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.16. Italy Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.17. Turkey Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.18. Turkey Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.19. Turkey Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.20. Turkey Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.21. Russia Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.22. Russia Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.23. Russia Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.24. Russia Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.25. Rest of Europe Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.26. Rest of Europe Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.27. Rest of Europe Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.28. Rest of Europe Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Growth Factors Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Transforming Growth Factors (TGF)
        • 6.1.1.1.1. Activin
        • 6.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 6.1.1.1.3. TGF-beta Proteins
      • 6.1.1.2. Epidermal Growth Factors (EGFs)
      • 6.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 6.1.1.4. Fibroblast Growth Factors (FGFs)
      • 6.1.1.5. Insulin-like Growth Factors (IGFs)
      • 6.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 6.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 6.1.1.8. Tumour Necrosis Factors (TNFs)
      • 6.1.1.9. Interleukins
      • 6.1.1.10. Others
  • 6.2. Asia Pacific Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. GMP Grade
      • 6.2.1.2. NON-GMP Grade
  • 6.3. Asia Pacific Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Oncology Research
      • 6.3.1.2. Hematology Research
      • 6.3.1.3. Wound Healing Research
      • 6.3.1.4. Dermatology Research
      • 6.3.1.5. Cardiovascular Disease & Diabetes
      • 6.3.1.6. Cell therapy and Ex vivo manufacturing
      • 6.3.1.7. Others
  • 6.4. Asia Pacific Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Pharmaceutical and Biotechnology Companies
      • 6.4.1.2. Research Centres & Academic Institutes
      • 6.4.1.3. CMO and CDMO
  • 6.5. Asia Pacific Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.2. China Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.3. China Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.4. China Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.5. Japan Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.6. Japan Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.7. Japan Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.8. Japan Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.9. South Korea Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.10. South Korea Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.11. South Korea Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.12. South Korea Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.13. India Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.14. India Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.15. India Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.16. India Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.17. Southeast Asia Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.18. Southeast Asia Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.19. Southeast Asia Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.20. Southeast Asia Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Growth Factors Market Outlook, 2018 - 2031

  • 7.1. Latin America Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Transforming Growth Factors (TGF)
        • 7.1.1.1.1. Activin
        • 7.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 7.1.1.1.3. TGF-beta Proteins
      • 7.1.1.2. Epidermal Growth Factors (EGFs)
      • 7.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 7.1.1.4. Fibroblast Growth Factors (FGFs)
      • 7.1.1.5. Insulin-like Growth Factors (IGFs)
      • 7.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 7.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 7.1.1.8. Tumour Necrosis Factors (TNFs)
      • 7.1.1.9. Interleukins
      • 7.1.1.10. Others
  • 7.2. Latin America Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.1. GMP Grade
      • 7.2.1.2. NON-GMP Grade
  • 7.3. Latin America Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Oncology Research
      • 7.3.1.2. Hematology Research
      • 7.3.1.3. Wound Healing Research
      • 7.3.1.4. Dermatology Research
      • 7.3.1.5. Cardiovascular Disease & Diabetes
      • 7.3.1.6. Cell therapy and Ex vivo manufacturing
      • 7.3.1.7. Others
  • 7.4. Latin America Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Pharmaceutical and Biotechnology Companies
      • 7.4.1.2. Research Centres & Academic Institutes
      • 7.4.1.3. CMO and CDMO
  • 7.5. Latin America Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.2. Brazil Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.3. Brazil Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.4. Brazil Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.5. Mexico Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.6. Mexico Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.7. Mexico Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.8. Mexico Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.9. Argentina Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.10. Argentina Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.11. Argentina Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.12. Argentina Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Growth Factors Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Transforming Growth Factors (TGF)
        • 8.1.1.1.1. Activin
        • 8.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
        • 8.1.1.1.3. TGF-beta Proteins
      • 8.1.1.2. Epidermal Growth Factors (EGFs)
      • 8.1.1.3. Platelet-Derived Growth Factors (PDGFs)
      • 8.1.1.4. Fibroblast Growth Factors (FGFs)
      • 8.1.1.5. Insulin-like Growth Factors (IGFs)
      • 8.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
      • 8.1.1.7. Hepatocyte Growth Factors (HGFs)
      • 8.1.1.8. Tumour Necrosis Factors (TNFs)
      • 8.1.1.9. Interleukins
      • 8.1.1.10. Others
  • 8.2. Middle East & Africa Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. GMP Grade
      • 8.2.1.2. NON-GMP Grade
  • 8.3. Middle East & Africa Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Oncology Research
      • 8.3.1.2. Hematology Research
      • 8.3.1.3. Wound Healing Research
      • 8.3.1.4. Dermatology Research
      • 8.3.1.5. Cardiovascular Disease & Diabetes
      • 8.3.1.6. Cell therapy and Ex vivo manufacturing
      • 8.3.1.7. Others
  • 8.4. Middle East & Africa Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Pharmaceutical and Biotechnology Companies
      • 8.4.1.2. Research Centres & Academic Institutes
      • 8.4.1.3. CMO and CDMO
  • 8.5. Middle East & Africa Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.2. GCC Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.3. GCC Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.4. GCC Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.5. South Africa Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.6. South Africa Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.7. South Africa Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.8. South Africa Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.9. Egypt Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.10. Egypt Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.11. Egypt Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.12. Egypt Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.13. Nigeria Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.14. Nigeria Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.15. Nigeria Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.16. Nigeria Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. by Application vs by Grade Heatmap
  • 9.2. Manufacturer vs by Grade Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Thermo Fisher Scientific Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Lonza Group AG
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Merck KGaA
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. General Electronics Company
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. F. Hoffmann-La Roche Ltd
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Applied Biological Materials (abm), Inc
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Abcam plc.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Cell Signaling Technology, Inc.
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
      • 9.5.8.5. Meridian Bioscience Inc.
      • 9.5.8.6. Company Overview
      • 9.5.8.7. Product Portfolio
      • 9.5.8.8. Financial Overview
      • 9.5.8.9. Business Strategies and Development
    • 9.5.9. Sartorius CellGenix GmbH
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Bio-Techne
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Proteintech Group, Inc
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Miltenyi Biotec
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. Creative Bioarray
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Akron Biotech
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development
    • 9.5.15. Sino Biological Inc.
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Product Portfolio
      • 9.5.15.3. Financial Overview
      • 9.5.15.4. Business Strategies and Development
    • 9.5.16. Repligen corporation
      • 9.5.16.1. Company Overview
      • 9.5.16.2. Product Portfolio
      • 9.5.16.3. Financial Overview
      • 9.5.16.4. Business Strategies and Development
    • 9.5.17. LEADGENE BIOMEDICAL, INC.
      • 9.5.17.1. Company Overview
      • 9.5.17.2. Product Portfolio
      • 9.5.17.3. Financial Overview
      • 9.5.17.4. Business Strategies and Development
    • 9.5.18. PeproTech In
      • 9.5.18.1. Company Overview
      • 9.5.18.2. Product Portfolio
      • 9.5.18.3. Financial Overview
      • 9.5.18.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations